The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
People with Type 1 or Type 2 diabetes make up over a quarter of those waiting for an organ transplant in Wisconsin.
Wade said on his podcast that he had the surgery in 2023.
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
Around 5.6 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK ...
A lack of essential micronutrients, such as vitamin D and magnesium, as well as a few others, may be behind 'hidden hunger' ...
Making the change can lower LDL cholesterol levels, keep blood sugar under control and promote better heart health ...
A MUM suffering severe bloating died after she had a suspected allergic reaction to a CT scan. Yvonne Graham, 66, went into ...
The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback